Evidence map›Paper›PMID 25344297›Full record

ArticleBMC veterinary research2014

Antibiotic susceptibility profiles of Mycoplasma bovis strains isolated from cattle in Hungary, Central Europe.

Kinga M Sulyok, Zsuzsa Kreizinger, Lilla Fekete, Veronika Hrivnák, Tibor Magyar, Szilárd Jánosi, Nóra Schweitzer, Ibolya Turcsányi, László Makrai, Károly Erdélyi and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Genes required for survival and proliferation ofApplied and environmental microbiology · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Efficacy of Two Antibiotic-Extender Combinations onPathogens (Basel, Switzerland) · 2020
    Article
  13. Pathogens (Basel, Switzerland) · 2020
    Review
  14. Investigation of Macrolide Resistance Genotypes inPathogens (Basel, Switzerland) · 2020
    Article
  15. MonitoringPathogens (Basel, Switzerland) · 2020
    Article
  16. Pathogens (Basel, Switzerland) · 2020
    Article
  17. The Addition ofAnimals : an open access journal from MDPI · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Kinga M Sulyok
Zsuzsa Kreizinger
Lilla Fekete
Veronika Hrivnák
Tibor Magyar
Szilárd Jánosi
Nóra Schweitzer
Ibolya Turcsányi
László Makrai
Károly Erdélyi
Miklós Gyuranecz
National Food Chain Safety Office · HUCentre for Agricultural Research · HUHUN-REN Veterinary Medical Research Institute · HUHungarian Academy of Sciences · HUMagyar Agrár- és Élettudományi Egyetem · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMycoplasma bovis is a worldwide pathogen, causative agent of pneumonia, mastitis, arthritis, and a variety of other symptoms in cattle. The economic losses due to mycoplasma pneumonia could be reduced by antibiotic treatment. The aim of the present study was to determine the in vitro susceptibility of M. bovis strains isolated from cattle in Hungary to eleven antibiotics.

resultsMinimal inhibitory concentration (MIC) values of 35 M. bovis strains collected from different parts of Hungary between 2010 and 2013 were determined by the microbroth dilution method. Strains with high MIC values were found in the case of all applied antibiotics. The most effective antibiotics tested in vitro were fluoroquinolones (MIC90 danofloxacin 0.312 μg/ml, enrofloxacin 0.312 μg/ml, marbofloxacin 0.625 μg/ml). Our results confirm the observations of increasing MIC values to antibiotics commonly used in the therapy of mycoplasma infections, primarily to tetracyclines; tetracycline (MIC90 16 μg/ml) and oxytetracycline (MIC90 ≥ 64 μg/ml) and macrolides; tylosin (MIC90 ≥ 128 μg/ml) and tilmicosin (MIC90 ≥ 128 μg/ml). The growth of many M. bovis strains was not inhibited by gentamicin (MIC90 8 μg/ml), spectinomycin (MIC90 ≥ 256 μg/ml), florfenicol (MIC90 8 μg/ml) or lincomycin (MIC90 ≥ 64 μg/ml).

conclusionsOur results emphasize the necessity of periodic testing for antibiotic susceptibility in this geographic region. Based on our in vitro examinations, fluoroquinolones could be the most effective drugs for the therapy of M. bovis infections in Hungary. However, current antimicrobial use policies have to be taken into account to avoid further antibiotic resistance development and to reserve fluoroquinolones for the treatment of severe infections which have responded poorly to other classes of antimicrobials.

Indexed as

Drug Resistance, BacterialAnimalsAnti-Bacterial AgentsCattleCattle DiseasesHungaryMicrobial Sensitivity TestsMycoplasma bovisMycoplasma InfectionsAnti-Bacterial Agents

Identifiers

PMID25344297
PMCPMC4210529
OpenAlexW2078810825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.